USA: (+1) 929-659-6832 | EU: (+44) 73-0721-4177
info@cognitivemarketresearch.com
D&B D-U-N-S No : 85-356-3074
Home Company Profile Johnson & Johnson
Company Profile

Johnson & Johnson Company Profile

Sneha Mali Published 30 Aug 2024 Updated 30 Aug 2024

Company Profile

Johnson & Johnson Basic Information, Manufacturing Base, Sales Area, and Competitors

Sr. No.

Item

Description

1

Company Name

Johnson & Johnson

2

Website

www.jnj.com

3

Established Date

1886

4

Headquartered

United States

5

Market Position/ History

Johnson & Johnson company was founded in 1886. The company initially focused on producing sterile surgical dressings and sutures, setting new standards for cleanliness and quality in the medical industry.

In 1919, the company opened the Gilmour Plant near Montreal, its first factory outside of the United States. Further, in the 1930s, the company expanded operations to Argentina, Brazil, Mexico, and South Africa.

In 2013, the company acquired Aragon Pharmaceuticals, Inc., and in 2014, the company acquired Alios BioPharma, Inc.

In course of time, the company has acquired several companies including Actelion, Emerging Implant Technologies GmbH, Momenta Pharmaceuticals and others.

Johnson & Johnson operates through its 265 subsidiaries in over 60 countries and serves its products in over 175 countries.

6

Sales Area

Worldwide

7

Manufacturing Location

61 manufacturing facilities across the United States, Europe, Western Hemisphere, excluding the U.S., Africa, Asia and the Pacific

8

Ticker

NYSE: JNJ

9

No. of Employees

~131,900 employees

10

Competitors
  • Alcon Inc
  • Glaukos Corporation
  • AbbVie Inc (Allergan Plc.)
  • New World Medical
  • BVI
  • Santen Pharmaceutical Co., Ltd.
  • ISTAR MEDICAL SA.
  • Inami & CO.,Ltd.

11

CEO

Joaquin Duato

12

Ownership Type

Public

13

Contact Information

One Johnson & Johnson Plaza, New Brunswick, New Jersey 08933

Tel: (732) 524-0400

Business Segment/ Overview:

Johnson & Johnson and its subsidiaries (the Company) have approximately 131,900 employees worldwide engaged in the research and development, manufacture, and sale of a broad range of products in the healthcare field.  The Company conducts business in virtually all countries of the world with the primary focus on products related to human health and well-being.
Currently, the company is operating under two business segments: Innovative Medicine and MedTech. The Innovative Medicine segment is focused on the following therapeutic areas: Immunology (e.g., rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease and psoriasis), Infectious Diseases (e.g., HIV/AIDS), Neuroscience (e.g., mood disorders, neurodegenerative disorders and schizophrenia), Oncology (e.g., prostate cancer, hematologic malignancies, lung cancer and bladder cancer), Cardiovascular and Metabolism (e.g., thrombosis, diabetes and macular degeneration) and Pulmonary Hypertension (e.g., Pulmonary Arterial Hypertension). Further, The MedTech segment includes a broad portfolio of products used in the Interventional Solutions, Orthopaedics, Surgery and Vision categories. Interventional Solutions include electrophysiology products (Biosense Webster) to treat heart rhythm disorders, the heart recovery portfolio (Abiomed) which includes technologies to treat severe coronary artery disease requiring high-risk PCI or AMI cardiogenic shock, and Neurovascular care (Cerenovus) that treats hemorrhagic and ischemic stroke.   Johnson & Johnson Vision products include ACUVUE Brand contact lenses and TECNIS intraocular lenses for cataract surgery. These products are distributed to wholesalers, hospitals and retailers, and used predominantly in the professional fields by physicians, nurses, hospitals, eye care professionals and clinics.

Micro Invasive Glaucoma Surgery MIGS Device Product Types Specification

Product

Description

BAERVELDT Glaucoma Implants

The BAERVELDT BG 103-250, BAERVELDT BG 101-350 and BAERVELDT Pars Plana BG 102-350 Glaucoma Implants

Provide pressure control with a minimally invasive BAERVELDT Glaucoma Implant. Its fenestration system is designed to control bleb height and volume while a patented larger surface area enhances IOP control. When traditional glaucoma therapy can’t help the rising IOP, provide control with a BAERVELDT Glaucoma Implant.

Minimally Invasive

  • BAERVELDT Implants only require single-quadrant insertion, allowing for better IOP control than competing implants.4,5
  • The BAERVELDT Implants’ patented bleb control mechanism allows fibrotic tissue growth through the fenestrations in the plate, controlling bleb height and volume.2,6
  • Minimizes the likelihood of ocular motility disturbances5
  • Helps ensure a low profile for better globe fit

BAERVELDT BG 103-250 Glaucoma Implant

Specifications

  • Surface Area: 250 mm2
  • Plate Length: 22 mm
  • Tube Length: 32 mm
  • Fenestrations: 4
  • Placement: Anterior chamber
  • Drainage Mechanism: Open tube

BAERVELDT BG 101-350 Glaucoma Implant

Specifications

  • Surface Area: 350 mm2
  • Plate Length: 32 mm
  • Tube Length: 32 mm
  • Fenestrations: 4
  • Placement: Anterior chamber
  • Drainage Mechanism: Open tube

BAERVELDT Pars Plana BG 102-350 Glaucoma Implant

Specifications

  • Surface Area: 350 mm2
  • Plate Length: 32 mm
  • Tube Length: 7 mm
  • Fenestrations: 4
  • Placement: Posterior chamber (Pars Plana)
  • Drainage Mechanism: Open tube with Hoffman Elbow

 

Sneha Mali
Sneha Mali  
Sneha Mali is a research analyst working in various domains including the Consumer Goods, market research and transport & logistics and her primary responsibility is to conduct thorough research on various subjects …
Share LinkedIn Facebook X/Twitter X Email

Profile Details

  • Author Sneha Mali
  • Published 30 Aug 2024
  • Last Updated 30 Aug 2024
  • Reading Time~5 minutes
  • CoverageSWOT, Financials, Key Employees, History

Table of Contents

    • 1.1 About Johnson & Johnson
    • 1.2 Key Facts
    • 1.3 Key Employees
      • 1.3.1 Key Employee Biographies
    • 1.4 History
    • 1.5 Locations & Subsidiaries
      • 1.5.1 Head Office
      • 1.5.2 Other Locations & Subsidiaries
    • 2.1 Company Overview
    • 2.2 Business Segments
    • 2.3 R&D Overview
    • 2.4 Brands
    • 2.5 Key Company Statistics
    • 2.6 Key Financials (2015–2019)
    • 2.7 Share Holder Analysis
    • 2.8 Regional Presence
    • 2.9 Services Offered
    • 3.1 Strengths
    • 3.2 Weaknesses
    • 3.3 Opportunities
    • 3.4 Threats
    • 3.5 Key Competitors
    • 4.1 Company Metrics
    • 4.2 Key Investors
    • 4.3 Recent Funding & Valuation
    • 4.4 Historical Funding & Valuation
    • 5.1 Acquisitions
    • 5.2 Partnerships
    • 6.1 Latest News & Announcements
    • 6.2 Strategic Initiatives
    • 7.1 Summary of Findings
    • 7.2 Strategic Recommendations

Get a Custom Profile

Need a tailored company profile or competitive intelligence report? Our analysts are ready to help.

Contact Our Experts

More Profiles

Explore all published company profiles across 30+ industry verticals.

View All Profiles